Tags

Bioscience partner Fosun

Accro Bioscience secures China regulatory clearance for vitiligo trial

Accro Bioscience secures China regulatory clearance for vitiligo trial

September 10, 2026 | 10:57
Accro Bioscience partner Fosun Pharma received investigational new drug clearance from China NMPA to begin Phase II/III clinical trials of TYK2/JAK1 inhibitor AC-201 for non-segmental vitiligo.

Latest News

VCCI releases 2025 competitiveness index with major upgrade

VCCI releases 2025 competitiveness index with major upgrade

Vietnam seeks to deepen financial cooperation with Russia

Vietnam seeks to deepen financial cooperation with Russia

Vietnam tops ASEAN as most attractive to European businesses

Vietnam tops ASEAN as most attractive to European businesses

Vietnam's life insurance sector eyes growth amid widening protection gap

Vietnam's life insurance sector eyes growth amid widening protection gap

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020